Wealth Awesome
TSX open
Loading markets…
Interactive Brokers: IBKR clients beat the S&P 500 in 2025 — 19.20% average client return vs 17.9% for the index, net of commissions and charges.
ETF Comparison · Canada
IBB
iShares Biotechnology ETF
vs
HHL
Harvest Healthcare Leaders Income ETF

A side-by-side comparison of iShares Biotechnology ETF (IBB) and Harvest Healthcare Leaders Income ETF (HHL) to help Canadian investors make an informed decision.

IBB
iShares Biotechnology ETF
Price
$203.72
YTD Return
+17.46%
AUM
$11.41B
MER
0.45%
52W High
$222.29
52W Low
$159.65
HHL
Harvest Healthcare Leaders Income ETF
Price
$7.46
YTD Return
-3.37%
AUM
$1.98B
MER
—
52W High
$8.04
52W Low
$6.35

1-Year Performance

Normalised to 100 at the start — shows relative return over the trailing 12 months.

IBBHHLBase = 100 (1 year ago)
-11.7%-3.9%4.0%11.8%19.7%27.5%Nov 20Feb 23May 26Aug 21Nov 19

Head-to-Head Comparison

MetricIBBHHL
YTD Return+17.46%✓-3.37%
1-Day Change-0.81%✓-1.91%
1-Week Change-4.55%-4.48%✓
1-Month Change-3.70%✓-1.84%
Current Price$203.72$7.46
AUM$11.41B✓$1.98B
MER (Expense Ratio)0.45%—
Dividend Yield0.16%9.32%✓
Distribution Frequency——
Inception Date2001-02-052014-12-18
Holdings Count23610
MorningStar Rating——
CategoryHealthcare EquityHealthcare Equity
Beta0.600.96
52-Week High$222.29$8.04
52-Week Low$159.65$6.35
50-Day MA$208.95$7.48
200-Day MA$186.82$7.27

✓ marks the better value for return/yield/AUM metrics. Lower ✓ for MER.

Annualised Returns

PeriodIBBHHL
YTD+17.46%✓-3.37%
1 Year+33.04%✓+12.26%
3 Year+23.63%✓+10.96%
5 Year+7.39%+7.77%✓
10 Year+8.83%✓+8.61%
1Y Volatility18.42%13.91%
Sharpe Ratio (3Y)1.030.67

Past performance is not a guarantee of future results.

Top 10 Holdings

IBB Holdings
1GILDGilead Sciences Inc9.21%
2AMGNAmgen Inc8.31%
3VRTXVertex Pharmaceuticals Inc8.14%
4REGNRegeneron Pharmaceuticals Inc6.75%
5MRNAModerna Inc5.80%
6ARGXargenx NV ADR3.84%
7NTRANatera Inc2.86%
8BIIBBiogen Inc2.70%
9ONCBeOne Medicines AG2.38%
10RVMDRevolution Medicines Inc2.19%
HHL Holdings
1REGNRegeneron Pharmaceuticals Inc5.20%
2AZNAstraZeneca PLC5.00%
3BMYBristol-Myers Squibb Company4.91%
4ABTAbbott Laboratories4.89%
5LLYEli Lilly and Company4.96%
6MRKMerck & Company Inc5.20%
7VRTXVertex Pharmaceuticals Inc4.86%
8NVSNovartis AG ADR4.75%
9DHRDanaher Corporation4.98%
10ABBVAbbVie Inc4.93%

Sector Weights

SectorIBBHHL
Basic Materials0.00%0.00%
Communication Services0.00%0.00%
Consumer Cyclicals0.00%0.00%
Consumer Defensive0.00%0.00%
Energy0.00%0.00%
Financial Services0.00%0.00%
Healthcare100.00%100.00%
Industrials0.00%0.00%
Real Estate0.00%0.00%
Technology0.00%0.00%
Utilities0.00%0.00%

About IBB

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

About HHL

US healthcare companies combine innovation with consistent demand. We all need healthcare, especially as the developed world ages and the developing world gets richer. Healthcare companies create value from new drugs, treatments, and technologies. HHL offers steady income and growth opportunities from large-cap US healthcare leaders.

Which ETF is Right for You?

Both IBB and HHL are listed on Canadian exchanges and accessible through most Canadian brokerages including Questrade, Wealthsimple Trade, TD Direct, and Interactive Brokers.

Based on the available data, IBB scores higher across our tracked metrics including YTD performance, dividend yield, and AUM — though both ETFs warrant individual research before investing.

  • Consider your account type (TFSA, RRSP, non-registered) as it can affect dividend taxation.
  • Compare management expense ratios (MER) directly on each provider's website.
  • Look at average daily trading volume to assess liquidity.
  • Review the fund's underlying index and holdings to ensure the exposure matches your goals.

This is not financial advice. Always do your own research or consult a licensed financial advisor before investing.

Frequently Asked Questions

What is the difference between IBB and HHL?

IBB (iShares Biotechnology ETF) and HHL (Harvest Healthcare Leaders Income ETF) are both Canadian-listed ETFs. Key differences include their AUM ($11.41B vs $1.98B), dividend yield (0.16% vs 9.32%), and year-to-date performance (+17.46% vs -3.37%).

Is IBB better than HHL?

There is no single "better" ETF — it depends on your investment goals. If you prioritise recent performance, IBB has outperformed year-to-date. Always review the fund's prospectus and consider your tax situation.

Can I buy IBB and HHL on Wealthsimple?

Most Canadian-listed ETFs are available on Wealthsimple Trade commission-free. Both IBB and HHL should be accessible. Check Wealthsimple's supported tickers list to confirm availability.

Free newsletter · Every Saturday morning

The Saturday TSX Wrap

The week on the TSX, in five minutes.

  • The biggest gainers and losers, and why they moved
  • Sector and momentum moves at a glance
  • The Canadian market stories you missed

Free. One email a week. Unsubscribe any time.

← ETF ScreenerETF Guides HubIBB ProfileHHL Profile